May 13, 2022 — Acutus Medical, an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced successful completion of patient enrollment in the company’s AcQForce Flutter Investigational Device Exemption (IDE) clinical trial which enrolled 110 patients at 21 sites globally.

May 13, 2022 — Vascular diseases are public enemy number one: the leading killers worldwide, accounting for nearly a third of all human deaths on the planet.

May 12, 2022 — Abbott announced a new partnership with Women as One to launch a new program designed to train more female and underrepresented physicians to pursue clinical trial research and help recruit clinical trial participants from historically underrepresented groups.

The global cardiogenic shock market was valued at US$ 3.29 Bn in 2021, and is expected to reach US$ 6.32 Bn by 2032, expanding at a CAGR of 6.2% over the 2022-2032 time frame.

The global cardiogenic shock market was valued at US$ 3.29 Bn in 2021, and is expected to reach US$ 6.32 Bn by 2032, expanding at a CAGR of 6.2% over the 2022-2032 time frame.

May 12, 2022 — Vivalink, a leading provider of digital healthcare solutions,
announced availability of the world’s first multi-vital blood pressure patch for remote patient
monitoring for use in commercial research and development. The advanced multimodal
continuous signal processing patch uses electrical signal-based technologies to capture ECG
trace, heart rate, respiratory rate, systolic and diastolic blood pressure on a single device. The

May 12, 2022 — NDA Partners General Manager, Eric Fish, announced today that Peter Mackrell, MD, a board certified vascular surgeon, has joined the company as an Expert Consultant.

May 11, 2022 — Women who experienced complications related to developing high blood pressure, or hypertension, during pregnancy had a 63% increased risk for developing

May 11, 2022 — Hypertrophic cardiomyopathy is a heart disease that leads to a stressed, swollen heart muscle. Due to a poor understanding of underlying mechanisms, effective clinical treatments are not available. Patients receive generic heart medication and sometimes need open-heart surgery to remove excess tissue.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now